KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Cash from Discontinued Operations: 2009-2024

Historic Cash from Discontinued Operations for Encompass Health (EHC) over the last 16 years, with FY2024 value amounting to -$3.1 million.

  • Encompass Health's Cash from Discontinued Operations rose 4000.0% to -$600000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.2 million, marking a year-over-year increase of 2727.27%. This contributed to the annual value of -$3.1 million for FY2024, which is 8062.5% up from last year.
  • Per Encompass Health's latest filing, its Cash from Discontinued Operations stood at -$3.1 million for FY2024, which was up 8062.5% from -$16.0 million recorded in FY2023.
  • Encompass Health's 5-year Cash from Discontinued Operations high stood at $151.1 million for FY2021, and its period low was -$16.0 million during FY2023.
  • In the last 5 years, Encompass Health's Cash from Discontinued Operations had a median value of $35.8 million in 2020 and averaged $44.0 million.
  • In the last 5 years, Encompass Health's Cash from Discontinued Operations soared by 91363.64% in 2020 and then plummeted by 13059.27% in 2023.
  • Over the past 5 years, Encompass Health's Cash from Discontinued Operations (Annual) stood at $35.8 million in 2020, then soared by 322.07% to $151.1 million in 2021, then plummeted by 65.39% to $52.3 million in 2022, then tumbled by 130.59% to -$16.0 million in 2023, then skyrocketed by 80.62% to -$3.1 million in 2024.
  • Its Cash from Discontinued Operations stands at -$3.1 million for FY2024, versus -$16.0 million for FY2023 and $52.3 million for FY2022.